In practical terms, research is shifting too
Why employer health plans might not invest in peoples long-term health This is one of the ways in which the US health systems reliance on employer-sponsored insurance fails us
They are not meant to treat anything or to promise a hormonal result
Clinical trial data from the SURMOUNT programme consistently shows greater weight loss with tirzepatide than with semaglutide at comparable doses, which is why Mounjaro has become the more commonly prescribed option for women starting GLP-1 treatment in the UK through private providers like SheMed
Decisions about starting, continuing, switching, or stopping any medication, including any GLP-1 receptor agonist, should be made in consultation with a licensed healthcare provider who knows your individual history, comorbidities, medications, and clinical context
BDNF-Val66Met variant and adolescent stress interact to promote susceptibility to anorexic behavior in mice